Company: OCEA
Filing Date: 2025-07-23
Form Type: 8-K
Source: 0001641172-25-020730
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-07-23
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting

On
July 17, 2025, Ocean Biomedical, Inc. (the “ Company”) received the decision of the Nasdaq Listing and Hearing Review Council
(the “ Listing Council”) pursuant to an appeal by the Company. On April 22, 2025, the Nasdaq Hearings Panel (the “ Panel”)
issued a decision to delist the Company’s securities from The Nasdaq Stock Market, LLC (the “ Exchange” or “ Nasdaq”)
and suspend trading of the Company’s shares, effective at the opening of business on April 24, 2025. The Company appealed the Panel’s
decision to the Listing Council. After considering the written record in this matter, the Listing Council affirms the Panel’s decision
to delist the Company from the Nasdaq affirming Nasdaq’s delist decision letter dated April 22, 2025.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
July 23, 2025

  OCEAN                                      
  By:                   /s/                  
                        Chirinjeev           
                        Chairman